[
    {
        "other_ids": [],
        "amendment_date": null,
        "keywords": [
            "atypical BRAF",
            "non-V600"
        ],
        "dcp_id": null,
        "interventional_model": "SEQUENTIAL_ASSIGNMENT",
        "lead_org": "BioMed Valley Discoveries, Inc",
        "eligibility": {
            "unstructured": [
                {
                    "inclusion_indicator": true,
                    "display_order": 0,
                    "description": "Patients with a locally advanced or metastatic malignancy, that has progressed following systemic therapy for their disease, if available, or for which the patient is not a candidate or refuses."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 1,
                    "description": "Tumors harboring a MEK or atypical BRAF alteration."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 2,
                    "description": "Provide signed and dated informed consent prior to initiation of any study-related procedures that are not considered standard of care (SoC)."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 3,
                    "description": "Male or female patients aged \u226518 years."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 4,
                    "description": "Patients must have measurable disease by RECIST version 1.1."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 5,
                    "description": "Eastern Cooperative Oncology Group (ECOG) performance status of 0 - 2."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 6,
                    "description": "Adequate renal function [creatinine \u22641.5 times ULN (upper limit of normal)] or a glomerular filtration rate (GFR) of \u226550 mL/min (using Cockcroft-Gault)."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 7,
                    "description": "Adequate hepatic function [total bilirubin \u22641.5 times ULN; AST (aspartate transaminase) and ALT (alanine transaminase) \u22643 times ULN or \u22645 times ULN if the elevation is due to liver involvement by tumor]."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 8,
                    "description": "Adequate bone marrow function (hemoglobin \u22659.0 g/dL; platelets \u2265100 x 109 cells/L; absolute neutrophil count \u22651.5 x 109 cells/L)."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 9,
                    "description": "Adequate cardiac function: Left ventricular ejection fraction (LVEF) of >50% as assessed by multi-gated acquisition (MUGA) or ultrasound/echocardiography (ECHO); and a corrected QT interval (QTc) <480ms by the Fridericia method (QTcF)."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 10,
                    "description": "Contraception - women: Negative pregnancy test for females of child-bearing potential; must be surgically sterile, postmenopausal (no menstrual cycle for at least 12 consecutive months), or compliant with a medically approved contraceptive regimen during and for 3 months after the last administration of study drug. Abstinence is not considered an adequate contraceptive regimen."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 11,
                    "description": "Contraception - men: Must be surgically sterile, or compliant with a medically approved contraceptive regimen during and for 3 months after the last administration of study drug."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 12,
                    "description": "Willing and able to participate in the trial and comply with all trial requirements."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 13,
                    "description": "Patients with a prior or concurrent malignancy whose natural history or treatment does not have the potential to interfere with the safety or efficacy assessment of the investigational agent may be included after consultation with the medical monitor."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 14,
                    "description": "Gastrointestinal (GI) condition that could impair absorption of study medication (specific cases e.g., remote history of GI surgery, may be enrolled after discussion with the medical monitor) or inability to ingest study medication."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 15,
                    "description": "Uncontrolled or severe intercurrent medical condition."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 16,
                    "description": "Known uncontrolled brain metastases. Stable brain metastases either treated or being treated with a stable dose of steroids/anticonvulsants, with no dose change in the previous 4 weeks, can be allowed."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 17,
                    "description": "Having received any cancer-directed therapy (chemotherapy, hormonal therapy, biologic or immunotherapy, etc.) within 28 days or 5 half-lives (whichever is shorter) prior to the first dose of study drug. Patients previously treated with radiotherapy must have recovered from the acute toxicities associated with such treatment."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 18,
                    "description": "Major surgery within 4 weeks prior to first dose."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 19,
                    "description": "Any use of an investigational drug within 28 days or 5 half-lives (whichever is shorter) prior to the first dose of study drug. A minimum of 10 days between termination of the prior investigational drug and administration of study drug is required. In addition, any drug-related toxicity except alopecia should have recovered to Grade 1 or less."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 20,
                    "description": "Prior therapy with any ERK inhibitor (e.g. LY3214996, LTT462)."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 21,
                    "description": "Groups 1-4: Prior therapy with any BRAF and/or MEK inhibitor (e.g. encorafenib, dabrafenib, vemurafenib, binimetinib, trametinib, cobimetinib) is excluded. Prior BRAF and/or MEK inhibitor therapy is permitted for Groups 5 and 6."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 22,
                    "description": "For Part B, agents targeting BRAF or MEK kinases and experimental agents are not permitted as physician's choice"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 23,
                    "description": "Pregnant or breast-feeding women."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 24,
                    "description": "Any evidence of serious active infections. Patients are allowed to enroll if they have been fever-free for at least 48 hours and are on an active treatment that is not prohibited in Appendix 1 of the protocol."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 25,
                    "description": "Any important medical illness or abnormal laboratory finding that would increase the risk of participating in this study (based on the investigator's judgment)."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 26,
                    "description": "A history or current evidence/risk of retinal vein occlusion (RVO) or central serous retinopathy (CSR)."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 27,
                    "description": "Concurrent therapy with any other investigational agent."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 28,
                    "description": "Concurrent therapy with drugs known to be strong inhibitors or inducers of CYP1A2, CYP2D6, and CYP3A4."
                }
            ],
            "structured": {
                "max_age": "999 Years",
                "max_age_number": 999.0,
                "min_age_unit": "Years",
                "max_age_unit": "Years",
                "max_age_in_years": 999.0,
                "gender": "BOTH",
                "accepts_healthy_volunteers": false,
                "min_age": "18 Years",
                "min_age_number": 18.0,
                "min_age_in_years": 18.0
            }
        },
        "completion_date_type_code": "ANTICIPATED",
        "detail_description": "This multi-center, phase II study will be conducted in two parts and assess the clinical\r\n      benefit, safety, pharmacokinetics, and pharmacodynamics of ulixertinib (BVD-523) in patients\r\n      with advanced malignancies.\r\n\r\n      Part A (tumor histology agnostic) will be open label and enroll patients to one of six groups\r\n      based on their tumor alteration.\r\n\r\n        -  Group 1: Patients with tumors, other than colorectal cancer (CRC), having a BRAF\r\n           alteration that results in an amino acid change at positions G469, L485, or L597.\r\n\r\n        -  Group 2: Patients with tumors, other than CRC, having a defined Class 2 BRAF alteration\r\n           (see Appendix 2 of protocol).\r\n\r\n        -  Group 3: Patients with tumors, other than CRC, having an atypical BRAF alteration (non\r\n           V600) that is not specified in Group 1 or Group 2.\r\n\r\n        -  Group 4: Patients with CRC having any atypical BRAF alteration.\r\n\r\n        -  Group 5: Patients with tumors, other than CRC, harboring alterations in MEK1/2.\r\n\r\n        -  Group 6: Patients with CRC harboring alterations in MEK1/2.\r\n\r\n      Part B (tumor histology specific) will randomly enroll patients with one of up to three\r\n      specified tumor histologies to receive either ulixertinib or the physician's choice of\r\n      treatment in a 2:1 ratio. Tumors must harbor a specified MEK or atypical BRAF alteration. If\r\n      a patient progresses on physician's choice of treatment, crossover to the ulixertinib arm is\r\n      permitted.The specific histologies to be included in this part will be selected based on\r\n      available data and discussion with the clinical investigators, the medical monitor, and the\r\n      sponsor.",
        "official_title": "A Two-Part, Phase II, Multi-center Study of the ERK Inhibitor Ulixertinib (BVD-523) for Patients With Advanced Malignancies Harboring MEK or Atypical BRAF Alterations",
        "_phase_sort_order": 2,
        "collaborators": [],
        "associated_studies": [],
        "outcome_measures": [
            {
                "timeframe": "Single time point drawn at Visit 4/approximately day 15 (or whenever the patient reaches steady state).",
                "name": "Part A: Cmax of BVD-523 at steady state",
                "description": "Single time point taken prior to taking study drug (trough) at steady state. Steady state is defined as patients who have received at least 5 days, or 10 consecutive doses, of study drug.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Up to 30 months",
                "name": "Part A: Duration of Response (DOR) according to RECIST 1.1",
                "description": "Time from first response to disease progression (DP) or death; assessed until DP, death, or initiation of subsequent anticancer therapy. Patients with no event will be censored at the last available tumor assessment.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Up to 30 months",
                "name": "Part A: Overall Response Rate (ORR) according to RECIST 1.1",
                "description": "ORR will be defined as the percentage of patients achieving a Best Overall Response (BOR) of confirmed Complete Response (CR) and/or Partial Response (PR). Patients will be evaluated at baseline & at periodic follow-up visits through the time their participation in the study is complete.The best responses will occur at different time points for each patient.",
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "18 months",
                "name": "Part A: Overall Survival (OS) according to RECIST 1.1",
                "description": "OS will be defined as time from first day of study drug to death. Patients with no event will be censored at the last date the patient is known to be alive.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "18 months",
                "name": "Part A: Progression Free Survival (PFS) according to RECIST 1.1",
                "description": "PFS will be defined as time from first day of study drug to disease progression or death. Patients with no event will be censored at the last available tumor assessment. This analysis will be based on investigator assessment.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Up to 30 months",
                "name": "Part B: Duration of Response (DOR) of ulixertinib compared to physician's choice of treatment, according to RECIST 1.1",
                "description": "Time from first response to disease progression or death; assessed until DP, death, or initiation of subsequent anticancer therapy. Patients with no event will be censored at the last available tumor assessment.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Up to 30 months",
                "name": "Part B: Overall Response Rate (ORR) of ulixertinib compared to physician's choice of treatment, according to RECIST 1.1",
                "description": "ORR will be defined as the percentage of patients achieving a Best Overall Response (BOR) of confirmed Complete Response (CR) and/or Partial Response (PR). Patients will be evaluated at baseline & at periodic follow-up visits through the time their participation in the study is complete.The best responses will occur at different time points for each patient.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "18 months",
                "name": "Part B: Overall Survival (OS) of ulixertinib compared to physician's choice of treatment",
                "description": "OS will be defined time from first day of study drug to death. Patients with no event will be censored at the last date the patient is known to be alive.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "18 months",
                "name": "Part B: Progression Free Survival (PFS) according to RECIST 1.1",
                "description": "PFS will be defined as time from first day of study drug to disease progression as adjudicated by the independent review committee or death. Patients with no event will be censored at the last available tumor assessment.",
                "type_code": "PRIMARY"
            }
        ],
        "phase": "II",
        "central_contact": {
            "phone": null,
            "name": null,
            "type": null,
            "email": null
        },
        "primary_purpose": "TREATMENT",
        "number_of_arms": 3,
        "_study_protocol_type_sort_order": 0,
        "nct_id": "NCT04488003",
        "biomarkers": [
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "STK",
                    "Serine/Threonine Kinase Gene",
                    "Serine/Threonine-Protein Kinase Gene"
                ],
                "nci_thesaurus_concept_id": "C25873",
                "name": "Serine/Threonine Protein Kinase Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C25871",
                    "C25872",
                    "C21281",
                    "C16612",
                    "C25870"
                ],
                "parents": [
                    "C25872"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Genes"
                ],
                "nci_thesaurus_concept_id": "C16612",
                "name": "Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "branch"
                ],
                "ancestors": [],
                "parents": [],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "B-Raf Proto-Oncogene, Serine/Threonine Kinase Gene",
                    "BRAF"
                ],
                "nci_thesaurus_concept_id": "C18363",
                "name": "BRAF Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "reference_gene"
                ],
                "ancestors": [
                    "C25873",
                    "C25871",
                    "C25872",
                    "C21281",
                    "C16612",
                    "C25870"
                ],
                "parents": [
                    "C25873"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "MAP2K1",
                    "Mitogen-Activated Protein Kinase Kinase 1 Gene"
                ],
                "nci_thesaurus_concept_id": "C21222",
                "name": "MAP2K1 Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "reference_gene"
                ],
                "ancestors": [
                    "C25872",
                    "C25870",
                    "C16612",
                    "C25871",
                    "C20921",
                    "C21281"
                ],
                "parents": [
                    "C20921",
                    "C25872"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "AA_MUTATION",
                    "Gene Product Sequence Variant",
                    "amino acid change",
                    "amino_acid_change"
                ],
                "nci_thesaurus_concept_id": "C97928",
                "name": "Gene Product Sequence Variation",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "ancestors": [
                    "C97926",
                    "C3910"
                ],
                "parents": [
                    "C97926"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "GENETIC_SEQ",
                    "Gene Mutant",
                    "Gene Mutation",
                    "Gene Variation",
                    "alternative"
                ],
                "nci_thesaurus_concept_id": "C97927",
                "name": "Gene Variant",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "ancestors": [
                    "C3910",
                    "C97926",
                    "C36391"
                ],
                "parents": [
                    "C36391"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Proto-Oncogene, Signaling Factor",
                    "Signaling Gene"
                ],
                "nci_thesaurus_concept_id": "C20921",
                "name": "Signaling Pathway Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C16612"
                ],
                "parents": [
                    "C16612"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [
                    "MAPKK2 Gene Mutation",
                    "MEK2 Gene Mutation",
                    "MKK2 Gene Mutation",
                    "Mitogen-Activated Protein Kinase Kinase 2 Gene Mutation",
                    "PRKMK2 Gene Mutation"
                ],
                "nci_thesaurus_concept_id": "C153256",
                "name": "MAP2K2 Gene Mutation",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "ancestors": [
                    "C25872",
                    "C97927",
                    "C25870",
                    "C36391",
                    "C16612",
                    "C106606",
                    "C25871",
                    "C3910",
                    "C20921",
                    "C136422",
                    "C21281",
                    "C97926",
                    "C36327"
                ],
                "parents": [
                    "C106606",
                    "C136422",
                    "C97927"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "VARIANT_TYPE",
                    "molecular consequence",
                    "molecular_consequence"
                ],
                "nci_thesaurus_concept_id": "C97926",
                "name": "Molecular Sequence Variation",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "ancestors": [
                    "C3910"
                ],
                "parents": [
                    "C3910"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "A-Raf Proto-Oncogene, Serine/Threonine Kinase Gene",
                    "ARAF"
                ],
                "nci_thesaurus_concept_id": "C18354",
                "name": "ARAF Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "reference_gene"
                ],
                "ancestors": [
                    "C21281",
                    "C16612",
                    "C25871",
                    "C25873",
                    "C25872",
                    "C25870"
                ],
                "parents": [
                    "C25873"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Mutant RAF",
                    "Mutant RAF Family Gene",
                    "RAF Family Mutation",
                    "RAF Mutation",
                    "Rapidly Accelerated Fibrosarcoma Family Gene Mutation",
                    "Rapidly Accelerated Fibrosarcoma Family Kinase Gene Mutation"
                ],
                "nci_thesaurus_concept_id": "C136425",
                "name": "RAF Family Gene Mutation",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "ancestors": [
                    "C18354",
                    "C21281",
                    "C25871",
                    "C97926",
                    "C18363",
                    "C36327",
                    "C16612",
                    "C36391",
                    "C3910",
                    "C25873",
                    "C18338",
                    "C25872",
                    "C25870"
                ],
                "parents": [
                    "C18338",
                    "C18354",
                    "C18363",
                    "C36327"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Serine/Threonine-Protein Kinase B-raf Protein Variant"
                ],
                "nci_thesaurus_concept_id": "C98307",
                "name": "BRAF Protein Variant",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "ancestors": [
                    "C16612",
                    "C25871",
                    "C3910",
                    "C25873",
                    "C97926",
                    "C97928",
                    "C21281",
                    "C25872",
                    "C25870",
                    "C18363"
                ],
                "parents": [
                    "C18363",
                    "C97928"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [
                    "B-RAF Gene Mutation",
                    "B-RAF1 Gene Mutation",
                    "BRAF Mutation",
                    "BRAF1 Gene Mutation",
                    "v-raf Murine Sarcoma Viral Oncogene Homolog B1 Gene Mutation"
                ],
                "nci_thesaurus_concept_id": "C40430",
                "name": "BRAF Gene Mutation",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "ancestors": [
                    "C18354",
                    "C21281",
                    "C25871",
                    "C97926",
                    "C18363",
                    "C36327",
                    "C16612",
                    "C136425",
                    "C36391",
                    "C3910",
                    "C25873",
                    "C18338",
                    "C97927",
                    "C25870",
                    "C25872"
                ],
                "parents": [
                    "C136425",
                    "C18363",
                    "C97927"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [
                    "BRAF Codon 597 Mutation",
                    "BRAF L597 Mutation",
                    "BRAF L597X",
                    "BRAF Leu597Xxx",
                    "BRAF NP_004324.2:p.Leu597Xxx",
                    "BRAF p.L597X",
                    "BRAF p.Leu597Xxx",
                    "NP_004324.2:p.L597X",
                    "NP_004324.2:p.Leu597Xxx",
                    "Serine/Threonine-Protein Kinase B-raf L597X",
                    "Serine/Threonine-Protein Kinase B-raf Leu597Xxx"
                ],
                "nci_thesaurus_concept_id": "C177448",
                "name": "BRAF NP_004324.2:p.L597X",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "ancestors": [
                    "C25872",
                    "C18363",
                    "C25870",
                    "C98307",
                    "C16612",
                    "C97928",
                    "C21281",
                    "C25871",
                    "C97926",
                    "C25873",
                    "C3910"
                ],
                "parents": [
                    "C18363",
                    "C98307"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C21281",
                "name": "Enzyme Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C16612"
                ],
                "parents": [
                    "C16612"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C25872",
                "name": "Kinase Family Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C25871",
                    "C21281",
                    "C25870",
                    "C16612"
                ],
                "parents": [
                    "C25871"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [
                    "BRAF Codon 469 Mutation",
                    "BRAF G469 Mutation",
                    "BRAF G469X",
                    "BRAF Gly469Xxx",
                    "BRAF NP_004324.2:p.Gly469Xxx",
                    "BRAF p.G469X",
                    "BRAF p.Gly469Xxx",
                    "NP_004324.2:p.G469X",
                    "NP_004324.2:p.Gly469Xxx",
                    "Serine/Threonine-Protein Kinase B-raf G469X",
                    "Serine/Threonine-Protein Kinase B-raf Gly469Xxx"
                ],
                "nci_thesaurus_concept_id": "C177443",
                "name": "BRAF NP_004324.2:p.G469X",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "ancestors": [
                    "C25872",
                    "C18363",
                    "C25870",
                    "C98307",
                    "C16612",
                    "C97928",
                    "C21281",
                    "C25871",
                    "C97926",
                    "C25873",
                    "C3910"
                ],
                "parents": [
                    "C18363",
                    "C98307"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "RAF1",
                    "v-RAF-1 Murine Leukemia Viral Oncogene Homolog 1Gene"
                ],
                "nci_thesaurus_concept_id": "C18338",
                "name": "RAF1 Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "reference_gene"
                ],
                "ancestors": [
                    "C21281",
                    "C16612",
                    "C25871",
                    "C25873",
                    "C25872",
                    "C25870"
                ],
                "parents": [
                    "C25873"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C25870",
                "name": "Transferase Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C21281",
                    "C16612"
                ],
                "parents": [
                    "C21281"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [
                    "Non-Codon 600 B-RAF Mutation",
                    "Non-Codon 600 B-RAF1 Mutation",
                    "Non-Codon 600 BRAF Gene Mutation",
                    "Non-Codon 600 BRAF Mutation",
                    "Non-Codon 600 BRAF1 Mutation",
                    "Non-V600 BRAF Mutation"
                ],
                "nci_thesaurus_concept_id": "C173449",
                "name": "Non-V600 BRAF Gene Mutation",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "ancestors": [
                    "C25872",
                    "C97927",
                    "C25870",
                    "C18354",
                    "C36391",
                    "C16612",
                    "C25871",
                    "C136425",
                    "C3910",
                    "C18363",
                    "C25873",
                    "C21281",
                    "C18338",
                    "C97926",
                    "C40430",
                    "C36327"
                ],
                "parents": [
                    "C18363",
                    "C40430"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C25871",
                "name": "Phosphotransferase Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C21281",
                    "C25870",
                    "C16612"
                ],
                "parents": [
                    "C25870"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C36327",
                "name": "Gene Abnormality",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "ancestors": [
                    "C97926",
                    "C36391",
                    "C3910"
                ],
                "parents": [
                    "C36391"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [
                    "MAPKK1 Gene Mutation",
                    "MEK1 Gene Mutation",
                    "MKK1 Gene Mutation",
                    "Mitogen-Activated Protein Kinase Kinase 1 Gene Mutation",
                    "PRKMK1 Gene Mutation"
                ],
                "nci_thesaurus_concept_id": "C147062",
                "name": "MAP2K1 Gene Mutation",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "ancestors": [
                    "C25872",
                    "C97927",
                    "C25870",
                    "C36391",
                    "C21222",
                    "C16612",
                    "C25871",
                    "C3910",
                    "C20921",
                    "C136422",
                    "C21281",
                    "C97926",
                    "C36327"
                ],
                "parents": [
                    "C136422",
                    "C21222",
                    "C97927"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Anomaly",
                    "DNA Sequence Variation",
                    "Genetic Abnormality",
                    "Genetic Alteration",
                    "Genetic Anomaly",
                    "Molecular Abnormality",
                    "Molecular Anomaly",
                    "Molecular Genetic Abnormality",
                    "Molecular Genetic Anomaly"
                ],
                "nci_thesaurus_concept_id": "C36391",
                "name": "Molecular Genetic Variation",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "ancestors": [
                    "C97926",
                    "C3910"
                ],
                "parents": [
                    "C97926"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [
                    "BRAF Codon 485 Mutation",
                    "BRAF L485 Mutation",
                    "BRAF L485X",
                    "BRAF Leu485Xxx",
                    "BRAF NP_004324.2:p.Leu485Xxx",
                    "BRAF p.L485X",
                    "BRAF p.Leu485Xxx",
                    "NP_004324.2:p.L485X",
                    "NP_004324.2:p.Leu485Xxx",
                    "Serine/Threonine-Protein Kinase B-raf L485X",
                    "Serine/Threonine-Protein Kinase B-raf Leu485Xxx"
                ],
                "nci_thesaurus_concept_id": "C177447",
                "name": "BRAF NP_004324.2:p.L485X",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "ancestors": [
                    "C25872",
                    "C18363",
                    "C25870",
                    "C98307",
                    "C16612",
                    "C97928",
                    "C21281",
                    "C25871",
                    "C97926",
                    "C25873",
                    "C3910"
                ],
                "parents": [
                    "C18363",
                    "C98307"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "MAP2K Family Gene Mutation",
                    "MAPKK Family Gene Mutation",
                    "MEK Family Mutation",
                    "MEK Mutation",
                    "Mitogen-Activated Protein Kinase Kinase Family Gene Mutation",
                    "Mutant MEK",
                    "Mutant MEK Family Gene"
                ],
                "nci_thesaurus_concept_id": "C136422",
                "name": "MEK Family Gene Mutation",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "ancestors": [
                    "C97926",
                    "C36391",
                    "C36327",
                    "C3910"
                ],
                "parents": [
                    "C36327"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "MAP2K2",
                    "Mitogen-Activated Protein Kinase Kinase 2 Gene"
                ],
                "nci_thesaurus_concept_id": "C106606",
                "name": "MAP2K2 Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "reference_gene"
                ],
                "ancestors": [
                    "C25872",
                    "C25870",
                    "C16612",
                    "C25871",
                    "C20921",
                    "C21281"
                ],
                "parents": [
                    "C20921",
                    "C25872"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Chromosomal, Gene, or Protein Abnormality",
                    "Cytogenetic or Molecular Genetic Abnormality",
                    "Genetic Abnormality",
                    "MOLECULAR_ABNORMALITY",
                    "Molecular Alteration"
                ],
                "nci_thesaurus_concept_id": "C3910",
                "name": "Molecular Abnormality",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [
                    "branch"
                ],
                "ancestors": [],
                "parents": [],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            }
        ],
        "classification_code": null,
        "current_trial_status_date": "2022-12-20",
        "diseases": [
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": true,
                "synonyms": [
                    "Metastatic Solid Neoplasm",
                    "Metastatic Malignant Solid Neoplasm",
                    "Metastatic Solid Tumor"
                ],
                "nci_thesaurus_concept_id": "C127155",
                "name": "Metastatic Malignant Solid Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36263",
                    "C132146"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Locally Advanced Solid Tumor",
                    "Locally Advanced Malignant Solid Neoplasm",
                    "Locally Advanced Solid Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C133093",
                "name": "Locally Advanced Malignant Solid Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C8524",
                    "C127155"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage III Colorectal Cancer AJCC v8",
                    "Stage III Colorectal Carcinoma AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C134191",
                "name": "Stage III Colorectal (Colon or Rectal) Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C134180"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IIIA Colorectal Carcinoma AJCC v8",
                    "Stage IIIA Colorectal Cancer AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C134192",
                "name": "Stage IIIA Colorectal (Colon or Rectal) Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C134191"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IIIB Colorectal Carcinoma AJCC v8",
                    "Stage IIIB Colorectal Cancer AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C134193",
                "name": "Stage IIIB Colorectal (Colon or Rectal) Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C134191"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IIIC Colorectal Cancer AJCC v8",
                    "Stage IIIC Colorectal Carcinoma AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C134194",
                "name": "Stage IIIC Colorectal (Colon or Rectal) Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C134191"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IV Colorectal Carcinoma AJCC v8",
                    "Stage IV Colorectal Cancer AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C134195",
                "name": "Stage IV Colorectal (Colon or Rectal) Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C134180"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IVA Colorectal Cancer AJCC v8",
                    "Stage IVA Colorectal Carcinoma AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C134196",
                "name": "Stage IVA Colorectal (Colon or Rectal) Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C134195"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IVB Colorectal Carcinoma AJCC v8",
                    "Stage IVB Colorectal Cancer AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C134197",
                "name": "Stage IVB Colorectal (Colon or Rectal) Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C134195"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IVC Colorectal Cancer AJCC v8",
                    "Stage IVC Colorectal Carcinoma AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C134198",
                "name": "Stage IVC Colorectal (Colon or Rectal) Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C134195"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C156096",
                "name": "Metastatic Colorectal Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C162780",
                    "C133839",
                    "C2955"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C162766",
                "name": "Locally Advanced Colorectal Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C156096",
                    "C153358"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Secondary Tumor",
                    "Tumor, secondary",
                    "Neoplasm, secondary"
                ],
                "nci_thesaurus_concept_id": "C36255",
                "name": "Secondary Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Solid Neoplasm",
                    "Solid Tumour",
                    "Solid tumor, NOS"
                ],
                "nci_thesaurus_concept_id": "C9292",
                "name": "Solid Tumor",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C7062",
                "name": "Neoplasm by Special Category",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm",
                    "Neoplasms, NOS",
                    "tumor",
                    "Neoplastic Growth",
                    "Tumor, NOS",
                    "Neoplasia",
                    "Neoplasm, NOS",
                    "Neoplastic Disease"
                ],
                "nci_thesaurus_concept_id": "C3262",
                "name": "Other Neoplasm",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C2991"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Secondary Cancer",
                    "Secondary Malignancy"
                ],
                "nci_thesaurus_concept_id": "C4968",
                "name": "Secondary Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36255",
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "disease term",
                    "Diseases",
                    "Disease",
                    "Diseases and Disorders",
                    "disease_term",
                    "Diagnosis",
                    "Disease or Disorder, Non-Neoplastic",
                    "disease type",
                    "Disorders",
                    "Disease or Disorder",
                    "Disorder",
                    "condition",
                    "disease_type"
                ],
                "nci_thesaurus_concept_id": "C2991",
                "name": "Other Disease",
                "type": [
                    "maintype"
                ],
                "parents": []
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Malignant Solid Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C132146",
                "name": "Malignant Solid Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9292",
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Tumor, metastatic",
                    "Metastatic Tumor",
                    "Neoplasm, metastatic",
                    "Metastatic"
                ],
                "nci_thesaurus_concept_id": "C3261",
                "name": "Metastatic Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm, malignant",
                    "Cancer",
                    "Tumor, malignant, NOS",
                    "Malignancy",
                    "Unclassified tumor, malignant",
                    "Malignant Neoplastic Disease",
                    "Malignant Growth",
                    "CA",
                    "Malignant Tumor"
                ],
                "nci_thesaurus_concept_id": "C9305",
                "name": "Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Metastatic Cancer"
                ],
                "nci_thesaurus_concept_id": "C36263",
                "name": "Metastatic Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4968",
                    "C3261"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Tumor_Morphology",
                    "Tumor Morphology"
                ],
                "nci_thesaurus_concept_id": "C4741",
                "name": "Neoplasm by Morphology",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Locally Advanced Cancer",
                    "regional cancer",
                    "Locally advanced",
                    "Locally Metastatic Malignant Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C8524",
                "name": "Locally Advanced Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C26801",
                "name": "Intestinal Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2990"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Epithelioma",
                    "Epithelioma, malignant",
                    "Epithelial Neoplasms, NOS"
                ],
                "nci_thesaurus_concept_id": "C3709",
                "name": "Epithelial Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4741"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Malignant Neoplasm of the Large Bowel",
                    "Malignant Neoplasm of the Large Intestine",
                    "Malignant Tumor of the Large Bowel",
                    "Malignant Tumor of the Large Intestine",
                    "Malignant Tumor of Large Intestine",
                    "Malignant Large Bowel Neoplasm",
                    "Malignant Neoplasm of Large Bowel",
                    "Malignant Neoplasm of Large Intestine",
                    "Malignant Tumor of Large Bowel",
                    "Malignant Colorectal Tumor",
                    "Malignant Large Intestine Neoplasm",
                    "Malignant Large Intestine Tumor",
                    "Malignant Large Bowel Tumor"
                ],
                "nci_thesaurus_concept_id": "C4978",
                "name": "Malignant Colorectal Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4572",
                    "C2956"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C153358",
                "name": "Locally Advanced Digestive System Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C148130",
                    "C179181",
                    "C133839"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C3263",
                "name": "Neoplasm by Site",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Tumor of the Digestive System",
                    "Digestive System Tumor",
                    "Digestive Neoplasm",
                    "Gastrointestinal Neoplasm",
                    "Gastrointestinal Tumor",
                    "Neoplasm of the GI System",
                    "Neoplasm of the Gastrointestinal System",
                    "Tumor of GI System",
                    "GI Neoplasm",
                    "Neoplasm of the Digestive System",
                    "Tumor of the GI System",
                    "Neoplasm of GI System",
                    "GI System Tumor",
                    "Neoplasm of Gastrointestinal System",
                    "Tumor of Gastrointestinal System",
                    "GI System Neoplasm",
                    "Neoplasm of Digestive System",
                    "Tumor of Digestive System",
                    "Tumor of the Gastrointestinal System",
                    "Digestive Tumor",
                    "GI Tumor",
                    "Gastrointestinal System Neoplasm",
                    "Gastrointestinal System Tumor"
                ],
                "nci_thesaurus_concept_id": "C3052",
                "name": "Digestive System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2990",
                    "C3263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Large Intestine Neoplasm",
                    "Large Intestine Tumor",
                    "Neoplasm of Large Bowel",
                    "Tumor of the Large Bowel",
                    "Large Bowel Tumor",
                    "Neoplasm of the Large Bowel",
                    "Large Bowel Neoplasm",
                    "Large Intestinal Neoplasm",
                    "Colorectal Tumor",
                    "Tumor of Large Bowel"
                ],
                "nci_thesaurus_concept_id": "C2956",
                "name": "Colorectal Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3141"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C162780",
                "name": "Metastatic Malignant Colorectal Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4978",
                    "C162255"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Malignant Epithelial Neoplasm",
                    "Epithelial tumor, malignant",
                    "Carcinoma",
                    "Carcinoma, NOS",
                    "Malignant Epithelioma",
                    "Epithelioma Malignant",
                    "CARCINOMA, MALIGNANT",
                    "Malignant Epithelial Tumor",
                    "Epithelial Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C2916",
                "name": "Other Carcinoma",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C9305",
                    "C3709"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Colorectal Carcinoma by AJCC v8 Stage"
                ],
                "nci_thesaurus_concept_id": "C134180",
                "name": "Colorectal Cancer by AJCC v8 Stage",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C2955"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C179181",
                "name": "Locally Advanced Malignant Digestive System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C8524",
                    "C162255"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Metastatic Digestive System Carcinoma",
                    "Metastatic Gastrointestinal System Carcinoma",
                    "Metastatic Gastrointestinal Carcinoma",
                    "Metastatic Gastrointestinal System Cancer"
                ],
                "nci_thesaurus_concept_id": "C133839",
                "name": "Metastatic Digestive System Cancer",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3482",
                    "C162255",
                    "C96963"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Disease by Site"
                ],
                "nci_thesaurus_concept_id": "C27551",
                "name": "Disorder by Site",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2991"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Disorder of Digestive System",
                    "Gastrointestinal System Disease",
                    "Digestive Disease",
                    "GI Disorder",
                    "Gastrointestinal Disorder",
                    "Digestive System Disease",
                    "Gastrointestinal System Disorder",
                    "Unspecified Gastrointestinal Problem",
                    "stomach or intestinal disorder"
                ],
                "nci_thesaurus_concept_id": "C2990",
                "name": "Digestive System Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27551"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Malignant Gastrointestinal System Neoplasm",
                    "Malignant Digestive System Neoplasm",
                    "Gastrointestinal System Cancer",
                    "Gastrointestinal cancer, NOS"
                ],
                "nci_thesaurus_concept_id": "C4890",
                "name": "Malignant Gastrointestinal Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305",
                    "C3052"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Large Intestine Carcinoma",
                    "Carcinoma of the Large Intestine",
                    "Colorectal Carcinoma",
                    "Cancer of Large Intestine",
                    "Carcinoma of the Large Bowel",
                    "Large Bowel Carcinoma",
                    "Cancer of the Large Intestine",
                    "Carcinoma of Large Intestine",
                    "Cancer of the Large Bowel",
                    "CRC",
                    "Colorectal Cancer",
                    "Large Bowel Cancer",
                    "Cancer of Large Bowel",
                    "Carcinoma of Large Bowel",
                    "Colorectal cancer, NOS",
                    "Large Intestine Cancer"
                ],
                "nci_thesaurus_concept_id": "C2955",
                "name": "Colorectal (Colon or Rectal) Cancer",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C4978",
                    "C96963"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Gastrointestinal System Carcinoma",
                    "Carcinoma of the Gastrointestinal System"
                ],
                "nci_thesaurus_concept_id": "C96963",
                "name": "Digestive System Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2916",
                    "C4890"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C36310",
                "name": "Secondary Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2916",
                    "C4968"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Bowel Cancer",
                    "Cancer of Intestine",
                    "Intestinal Neoplasms, Malignant",
                    "Malignant Intestinal Tumor",
                    "Intestinal Cancer",
                    "Malignant Intestinal Tumors",
                    "Malignant Intestinal Neoplasms",
                    "Malignant Neoplasm of Intestine",
                    "Malignant Neoplasm of the Intestine",
                    "Malignant Intestine Neoplasm",
                    "Malignant Tumor of Intestine",
                    "Intestinal Tumors, Malignant",
                    "Malignant Tumor of the Intestine",
                    "Malignant Intestine Tumor",
                    "Cancer of the Intestine"
                ],
                "nci_thesaurus_concept_id": "C4572",
                "name": "Malignant Intestinal Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3141",
                    "C4890"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C162255",
                "name": "Metastatic Malignant Digestive System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36263",
                    "C4890"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Carcinoma, metastatic, NOS"
                ],
                "nci_thesaurus_concept_id": "C3482",
                "name": "Metastatic Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36263",
                    "C36310"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C148130",
                "name": "Locally Advanced Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C8524",
                    "C3482"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Intestinal Tumor",
                    "Tumor of the Intestines",
                    "Intestinal Tumors",
                    "Neoplasm of Intestines",
                    "Intestinal Neoplasms",
                    "Neoplasm of the Intestines",
                    "Tumor of Intestines"
                ],
                "nci_thesaurus_concept_id": "C3141",
                "name": "Intestinal Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C26801",
                    "C3052"
                ]
            }
        ],
        "_primary_purpose_sort_order": 0,
        "protocol_id": "BVD-523-ABC",
        "active_sites_count": 6,
        "lead_org_cancer_center": null,
        "arms": [
            {
                "interventions": [
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Pharmacologic Agent",
                            "Drug Substance",
                            "Pharmaceuticals",
                            "Pharmaceutical Agent",
                            "Agent",
                            "Pharmacological Substance",
                            "Drug"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Enzyme Inhibitor Drug",
                            "Enzyme Antagonist",
                            "Enzyme Inhibitor Agent"
                        ],
                        "nci_thesaurus_concept_id": "C471",
                        "name": "Enzyme Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastic Protein Antagonist",
                            "Anti-cancer Protein Inhibitor"
                        ],
                        "nci_thesaurus_concept_id": "C129824",
                        "name": "Antineoplastic Protein Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C2189"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C61074",
                        "name": "Serine/Threonine Kinase Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1404"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C69145",
                        "name": "Mitogen-Activated Protein Kinase Kinase Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C163758",
                            "C1404"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C104744",
                        "name": "Ulixertinib",
                        "description": "An orally available inhibitor of extracellular signal-regulated kinase (ERK) 1 and 2, with potential antineoplastic activity. Upon oral administration, BVD-523 inhibits both ERK 1 and 2, thereby preventing the activation of ERK-mediated signal transduction pathways. This results in the inhibition of ERK-dependent tumor cell proliferation and survival. The mitogen-activated protein kinase (MAPK)/ERK pathway is often upregulated in a variety of tumor cell types and plays a key role in tumor cell proliferation, differentiation and survival. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)Health professional",
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C129825",
                            "C61074"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C155322",
                        "name": "BRAF Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C2336"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1404",
                        "name": "Protein Kinase Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C471"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Targeted Agent",
                            "Molecularly Targeted Therapy Agent",
                            "Targeted Therapeutic Agent",
                            "Anti-tumor Targeted Therapy Agent"
                        ],
                        "nci_thesaurus_concept_id": "C163758",
                        "name": "Targeted Therapy Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C2189",
                        "name": "Signal Transduction Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C2336",
                        "name": "Raf Kinase Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C163758",
                            "C61074"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Anti-cancer Enzyme Inhibitor"
                        ],
                        "nci_thesaurus_concept_id": "C129825",
                        "name": "Antineoplastic Enzyme Inhibitor",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C129824",
                            "C471"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antiproliferative Agents",
                            "Anti-Tumor Drugs",
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Tumor-Specific Treatment Agents",
                            "Anti-Tumor Agents",
                            "Cancer Drug",
                            "Antineoplastics",
                            "Anti-Cancer Agents",
                            "Antineoplastic Drugs",
                            "Antiproliferative Drugs"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    }
                ],
                "name": "Arm not specified",
                "description": null,
                "type": null
            },
            {
                "interventions": [],
                "name": "Part A: Ulixertinib",
                "description": "Oral, 600 mg, twice daily, for 28-days in each treatment cycle",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [],
                "name": "Part B: Physician's choice of treatment",
                "description": "Physician's choice will be restricted to two approved (not off-label) treatments for each tumor histology (agents targeting BRAF or MEK kinases and experimental agents are not permitted as physician choice). If a patient progresses on physician's choice of treatment, crossover to the ulixertinib arm is permitted.",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [],
                "name": "Part B: Ulixertinib",
                "description": "Oral, 600 mg, twice daily, for 28-days in each treatment cycle",
                "type": "EXPERIMENTAL"
            }
        ],
        "study_model_code": null,
        "nci_id": "NCI-2020-14000",
        "why_study_stopped": null,
        "brief_summary": "This BVD-523-ABC study builds on the safety and clinical activity experience of previous\r\n      studies that have evaluated ulixertinib as a novel targeted cancer treatment in cohorts of\r\n      patients with specific genetic alterations and tumor histologies that result in aberrant MAPK\r\n      pathway signaling. Early clinical data have demonstrated anti-tumor activity with ulixertinib\r\n      treatment and have identified specific groups of patients for whom additional development is\r\n      warranted.",
        "brief_title": "Study of Ulixertinib for Patients With Advanced Malignancies Harboring MEK or Atypical BRAF Alterations",
        "status_history": [
            {
                "status_date": "2022-12-20T00:00:00.000001",
                "status": "CLOSED_TO_ACCRUAL"
            },
            {
                "status_date": "2020-11-03T00:00:00",
                "status": "ACTIVE"
            }
        ],
        "study_population_description": null,
        "sampling_method_code": null,
        "minimum_target_accrual_number": 528,
        "prior_therapy": [],
        "_current_trial_status_sort_order": 7,
        "start_date": "2020-11-03",
        "record_verification_date": "2022-12-01",
        "ctep_id": null,
        "current_trial_status": "Closed to Accrual",
        "study_model_other_text": null,
        "masking": {
            "role_caregiver": null,
            "masking": null,
            "role_investigator": null,
            "role_outcome_assessor": null,
            "role_subject": null,
            "allocation_code": "Non-Randomized Trial"
        },
        "acronym": null,
        "nci_programs": [],
        "nci_funded": "Indirect",
        "anatomic_sites": [
            "Multiple"
        ],
        "ccr_id": null,
        "start_date_type_code": "ACTUAL",
        "principal_investigator": null,
        "study_source": "Industrial",
        "completion_date": "2023-08-01",
        "study_subtype_code": null,
        "study_protocol_type": "Interventional"
    }
]